The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a potential advance. Unlike shots, this technique offers a less invasive way to deliver GLP-1 drugs. These https://philipkqaw755822.spintheblog.com/41299931/glp-1-patches-a-new-approach-to-blood-sugar-treatment